Trimedyne, Inc. reported financial results for the first quarter ended December 31, 2013. Revenues for the quarter ended December 31, 2013, were $1,399,000, a 5.2% decrease from revenues of $1,475,000 for the prior year's quarter. The company had a net loss of $259,000 or $0.014 per share for the current quarter, compared to a loss of $144,000 or $0.008 per share for the same quarter of the prior year, based on a weighted average of 18,395,960 shares outstanding.